Mapping the scope of drug patents

Narrowing patents that claim more than they disclose would open space for rival innovators, not generics.

Authors

Institutions

Publication Details

Journal
Science
Published
2026-10-29
DOI
https://doi.org/10.1126/science.aeh0691
Primary Topic
Intellectual Property and Patents
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mapping the scope of drug patents

Kasper Dinkla, Janet Freilich, Lisa Larrimore Ouellette, Gerhard Ingmar Meijer
1 links
Science
Intellectual Property and Patents
article

Mapping the scope of drug patents

Kasper Dinkla, Janet Freilich, Lisa Larrimore Ouellette, Gerhard Ingmar Meijer
article en

Abstract

Narrowing patents that claim more than they disclose would open space for rival innovators, not generics.

ScienceVol. 394(6823)
Boston University (US), IBM Research - Zurich (CH), Stanford University (US)
Openalex Percentile: Top 68%
Intellectual Property and Patents
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Mapping the scope of drug patents — Kasper Dinkla, Janet Freilich, et al. · Science (2026) | TGRS Research Map | TGRS